Finch Therapeutics Group Inc. (FNCH) NASDAQ
$2.31 (0.48) (-17.35%)
Market Cap: $4.48M
As of 04/24/24 03:59 PM EDT. Market closed.
Finch Therapeutics Group Inc. (FNCH)
NASDAQ
$2.31
(0.48) (-17.35%)
Market Cap: $4.48M
As of 04/24/24 03:59 PM EDT. Market closed.
Add to Portfolio
finch therapeutics is unlocking the therapeutic potential of the microbiome through our human-first discovery platform. we use machine learning algorithms to reverse engineer successful fecal transplantations and other clinical datasets, identifying the microbes that drive responses in patients. this human-centric discovery model leverages clinical data to focus our in-vitro and in-vivo efforts ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
123
Address
.
PRICE CHART FOR FINCH THERAPEUTICS GROUP INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.52
Previous Close
$2.79
Days Range
$2.39 - $3.04
52 week range
$1.86 - $16.74
Volume
118,253
Avg. Volume (30 days)
91,041
Market Cap
$4.48M
Dividend Yield
-
P/E
(0.06)
Shares Outstanding
1,605,763
Open
$2.52
Previous Close
$2.79
Days Range
$2.39 - $3.04
52 week range
$1.86 - $16.74
Volume
118,253
Avg. Volume (30 days)
91,041
Market Cap
$4.48M
Dividend Yield
-
P/E
(0.06)
Shares Outstanding
1,605,763
FINANCIAL STATEMENTS FOR FINCH THERAPEUTICS GROUP INC
LOADING...
INSIDER TRANSACTIONS FOR FINCH THERAPEUTICS GROUP INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
SMISEK JEFFERY A | Director | Mar 28, 2024 | Sale | $2.57 | 6,642 | 17,070 | 0 | Mar 29, 2024, 04:15 PM |
SMISEK JEFFERY A | Director | Mar 28, 2024 | Sale | $2.61 | 1,600 | 4,176 | 6,512 | Mar 29, 2024, 04:15 PM |
SMISEK JEFFERY A | Director | Nov 22, 2023 | Sale | $3.64 | 1,470 | 5,351 | 6,642 | Nov 27, 2023, 04:54 PM |
Graf Susan E | Director | Jun 09, 2023 | Buy | $0.27 | 5,010 | 1,353 | 5,010 | Jun 09, 2023, 04:15 PM |
Blaustein Marc | Chief Operating Officer | Oct 21, 2022 | Sale | $1.39 | 3,636 | 5,054 | 32,614 | Oct 25, 2022, 04:31 PM |
Vittiglio Joseph | Chief Business & Legal Officer | Oct 21, 2022 | Sale | $1.39 | 3,636 | 5,054 | 31,364 | Oct 25, 2022, 04:25 PM |
Haft Nicholas | Director | Dec 20, 2021 | Buy | $10.18 | 63,850 | 649,993 | 4,056,907 | Dec 22, 2021, 06:21 PM |
SMISEK JEFFERY A | Director | Mar 23, 2021 | Buy | $17.00 | 88,235 | 1,499,995 | 1,694,541 | Mar 25, 2021, 06:08 PM |
Haft Nicholas | Director | Mar 23, 2021 | Buy | $17.00 | 882,351 | 14,999,967 | 882,351 | Mar 25, 2021, 06:05 PM |
FERRANTE DOMENIC J | Director | Mar 23, 2021 | Buy | $17.00 | 102,941 | 1,749,997 | 636,195 | Mar 25, 2021, 06:04 PM |
Crestovo Investor LLC | Director | Mar 23, 2021 | Buy | $17.00 | 735,294 | 12,499,998 | 12,641,441 | Mar 25, 2021, 06:01 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
SMISEK JEFFERY A | Director | 03/28/2024 | 17,070 |
SMISEK JEFFERY A | Director | 03/28/2024 | 4,176 |
SMISEK JEFFERY A | Director | 11/22/2023 | 5,351 |
Graf Susan E | Director | 06/09/2023 | 1,353 |
Blaustein Marc | Chief Operating Officer | 10/21/2022 | 5,054 |
Vittiglio Joseph | Chief Business & Legal Officer | 10/21/2022 | 5,054 |
Haft Nicholas | Director | 12/20/2021 | 649,993 |
SMISEK JEFFERY A | Director | 03/23/2021 | 1,499,995 |
Haft Nicholas | Director | 03/23/2021 | 14,999,967 |
FERRANTE DOMENIC J | Director | 03/23/2021 | 1,749,997 |
Crestovo Investor LLC | Director | 03/23/2021 | 12,499,998 |
Load More Insider Transactions
FUNDS WITH A POSITION IN FINCH THERAPEUTICS GROUP INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BAUPOST GROUP LLC/MA | 67,296 | 0.0053% | No change | Value |
RENAISSANCE TECHNOLOGIES LLC | 11,746 | 0.00007% | New | Other |
BLACKROCK INC. | 341 | 0% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR FINCH THERAPEUTICS GROUP INC
STOCK BUYBACKS FOR FINCH THERAPEUTICS GROUP INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.04%
1Q
06/30/2023
0.05%
2Q
03/31/2023
0.17%
3Q
12/31/2022
0.50%
4Q
09/30/2022
0.92%
5Q
06/30/2022
1.24%
6Q
03/31/2022
1.35%
7Q
12/31/2021
22.87%
8Q
09/30/2021
1.52%
9Q
06/30/2021
1.66%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR FINCH THERAPEUTICS GROUP INC
LOADING...